MENU
OVID
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ovid Therapeutics (OVID) Ownership - Who owns Ovid Therapeutics?
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
441 Ninth Avenue
Phone
+1 646 661-7661
Employees
40
Web
https://www.ovidrx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
24.39M
P/E Ratio
N/A
Total Cash
43M
Projected Growth
N/A
Total Debt
14.43M
Revenue
548K
Risk (Beta)
-0.22
Dividend Yield
N/A
Total Cash/Share
0.60
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
OVID
Capitalization
24.4M
P/E Ratio
N/A
Risk (Beta)
-0.22
Dividend Yield
N/A
Total Cash
43M
Total Cash/Share
0.60
Total Debt
14.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
548K
ROE
N/A
Book Value
59.3M
P/B Ratio
0.41
Cash Flow
N/A
Earnings
-0.34
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
71K
Current Ratio
4.93
Current Revenue Per Employee
5652.17
Dividends Per Share - Security
N/A
EBITDA
-56.4M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-23.42
Shares Held By Institutions
19.3M
Shares Outstanding - Current
71.1M
Total Liabilities
22.4M
Total Volume MTD
N/A
Value
1
Gain YTD
-66.317
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Provides medicines to children and adults with neurological disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
441 Ninth Avenue
Phone
+1 646 661-7661
Employees
40
Web
https://www.ovidrx.com